Asthma: moving toward a global children's charter

GSK Global Children's Asthma Group

doi:10.1016/S2213-2600(19)30074-8

Asthma: moving toward a global children's charter

GSK Global Children's Asthma Group

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	299-300
Number of pages	2
Journal	The Lancet Respiratory Medicine
Volume	7
Issue number	4
DOIs	https://doi.org/10.1016/S2213-2600(19)30074-8
State	Published - Apr 2019

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1016/S2213-2600(19)30074-8

Cite this

@article{72dbdc77ef6b486b93fe4aaae4bb3707,

title = "Asthma: moving toward a global children's charter",

author = "{GSK Global Children's Asthma Group} and Warren Lenney and Yuichi Adachi and Andrew Bush and Fischer, {Gilberto B.} and Jianguo Hong and Anders Ostrem and Soren Pedersen and Sly, {Peter D.} and Szefler, {Stanley J.} and Raj Tilak and Zar, {Heather J.} and Akinbami, {Lara J.} and Blake, {Kathryn V.} and Michael Cabana and Cicutto, {Lisa C.} and Adnan Custovic and Iolo Doull and Fitzgerald, {Dominic A.} and Monica Fletcher and Jonathan Grigg and Rod Hughes and Christina Keen and Leather, {David A.} and Lemanske, {Rob F.} and Louis Garcia-Marcos and Mazyck, {Donna J.} and Rubin, {Bruce K.} and Aziz Sheikh and Kunling Shen and Stein, {Renato T.} and Stout, {James W.} and Padmaja Subbarao and Tonya Winders and Sian Williams",

note = "Funding Information: WL reports being a GSK employee and a GSK shareholder. YA reports grants from Astellas, GSK, and Pfizer and personal fees from Merck Sharp & Dohme, GSK, and Kyorin Pharmaceuticals. SP reports personal fees from AstraZeneca, ALK, Thermo Fisher Scientific, and Phadia. SJS reports acting as a consultant for and research with Boehringer Ingleheim, Genentech, GSK, Aerocrine, AstraZeneca, Roche, Teva, Daiichi Sankyo, and Sanofi and grants from GSK and Propeller Health. HJZ reports grants from The Allergy Society of South Africa, South Africa Medical Research Council and personal fees from GSK, outside of the submitted work. All authors attended the Washington DC Forum meeting on October 31, 2018, and report their travel and accommodation expenses being met by GSK. All other authors declare no other competing interests. ",

year = "2019",

month = apr,

doi = "10.1016/S2213-2600(19)30074-8",

language = "English (US)",

volume = "7",

pages = "299--300",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

number = "4",

}

TY - JOUR

T1 - Asthma

T2 - moving toward a global children's charter

AU - GSK Global Children's Asthma Group

AU - Lenney, Warren

AU - Adachi, Yuichi

AU - Bush, Andrew

AU - Fischer, Gilberto B.

AU - Hong, Jianguo

AU - Ostrem, Anders

AU - Pedersen, Soren

AU - Sly, Peter D.

AU - Szefler, Stanley J.

AU - Tilak, Raj

AU - Zar, Heather J.

AU - Akinbami, Lara J.

AU - Blake, Kathryn V.

AU - Cabana, Michael

AU - Cicutto, Lisa C.

AU - Custovic, Adnan

AU - Doull, Iolo

AU - Fitzgerald, Dominic A.

AU - Fletcher, Monica

AU - Grigg, Jonathan

AU - Hughes, Rod

AU - Keen, Christina

AU - Leather, David A.

AU - Lemanske, Rob F.

AU - Garcia-Marcos, Louis

AU - Mazyck, Donna J.

AU - Rubin, Bruce K.

AU - Sheikh, Aziz

AU - Shen, Kunling

AU - Stein, Renato T.

AU - Stout, James W.

AU - Subbarao, Padmaja

AU - Winders, Tonya

AU - Williams, Sian

N1 - Funding Information: WL reports being a GSK employee and a GSK shareholder. YA reports grants from Astellas, GSK, and Pfizer and personal fees from Merck Sharp & Dohme, GSK, and Kyorin Pharmaceuticals. SP reports personal fees from AstraZeneca, ALK, Thermo Fisher Scientific, and Phadia. SJS reports acting as a consultant for and research with Boehringer Ingleheim, Genentech, GSK, Aerocrine, AstraZeneca, Roche, Teva, Daiichi Sankyo, and Sanofi and grants from GSK and Propeller Health. HJZ reports grants from The Allergy Society of South Africa, South Africa Medical Research Council and personal fees from GSK, outside of the submitted work. All authors attended the Washington DC Forum meeting on October 31, 2018, and report their travel and accommodation expenses being met by GSK. All other authors declare no other competing interests.

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85063215138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063215138&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(19)30074-8

DO - 10.1016/S2213-2600(19)30074-8

M3 - Comment/debate

C2 - 30803924

AN - SCOPUS:85063215138

SN - 2213-2600

VL - 7

SP - 299

EP - 300

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 4

ER -

Asthma: moving toward a global children's charter

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this